Which companies overlap with Istituto per la Ricerca e l'Innovazione Biomedica's portfolio?

Top competitors by shared drug class: Research in Real-Life Ltd, University Medical Center Groningen, GlaxoSmithKline, National Jewish Health, Chiesi Farmaceutici S.p.A..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/istituto-per-la-ricerca-e-l-innovazione-biomedica.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Istituto per la Ricerca e l'Innovazione Biomedica — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Istituto per la Ricerca e l'Innovazione Biomedica pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Resveratrol plus Carboxymethyl-β-Glucan	Resveratrol plus Carboxymethyl-β-Glucan	marketed	Nutraceutical combination / Dietary supplement		Immunology / Wellness
Nebulized beclomethasone dipropionate	Nebulized beclomethasone dipropionate	marketed	Inhaled corticosteroid	Glucocorticoid receptor	Respiratory
Symbicort Turbohaler without Turbo+	Symbicort Turbohaler without Turbo+	marketed	Inhaled corticosteroid/long-acting beta-2 agonist combination	Glucocorticoid receptor; beta-2 adrenergic receptor	Respiratory

Therapeutic area mix

Respiratory · 2
Immunology / Wellness · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Research in Real-Life Ltd · 2 shared drug classes
University Medical Center Groningen · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
National Jewish Health · 2 shared drug classes
Chiesi Farmaceutici S.p.A. · 2 shared drug classes
SkyePharma AG · 2 shared drug classes
AstraZeneca · 2 shared drug classes
University of Chicago · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Istituto per la Ricerca e l'Innovazione Biomedica:

Cite this brief

Drug Landscape (2026). Istituto per la Ricerca e l'Innovazione Biomedica — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/istituto-per-la-ricerca-e-l-innovazione-biomedica. Accessed 2026-05-17.